Search for a command to run...
Amerise Biosciences Ltd. stands out in a challenging sector, exhibiting unique financial metrics among its peers. Despite its lack of growth and profitability, the company is in a sector dominated by firms with high valuations and varying profitability levels. It appears less risky due to its zero debt, but its performance metrics indicate it may not be the best investment option currently.
Stocks | CMP | Market Cap | P/E | ROCE (%) | Debt/Equity |
---|---|---|---|---|---|
Amerise Biosciences Ltd. | ₹0.75 | ₹4.96Cr | 101.35 | - | - |
BAJAJFINSV | ₹1,944.65 | ₹3,10,494.49Cr | 247.44 | 13.20% | 4.82 |
AIIL | ₹3,221.70 | ₹54,718.96Cr | 13.36 | 30.27% | 0.07 |
CHOLAHLDNG | ₹1,758.35 | ₹33,017.77Cr | 512.70 | 11.60% | 13.26 |
JSWHL | ₹17,913.30 | ₹19,883.05Cr | 113.81 | 0.70% | - |
IIFL | ₹438.75 | ₹18,625.68Cr | -45.52 | 12.50% | 4.42 |
MAHSCOOTER | ₹16,133.30 | ₹18,438.10Cr | 76.36 | - | - |